Exploiting synthetic lethality to improve cancer therapy
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.46
Published Online: 2017-03-29
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brunen, Diede
Bernards, René
Text and Data Mining valid from 2017-03-29
Article History
First Online: 29 March 2017
Competing interests
: The authors declare no competing financial interests.